AstraZeneca PLC (AZN)
166.80
+0.82
(+0.49%)
USD |
NYSE |
Aug 24, 16:00
166.71
-0.09
(-0.05%)
After-Hours: 20:00
AstraZeneca Net Income (Quarterly) : 3.076B for March 31, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 3.076B |
| December 31, 2025 | 2.326B |
| September 30, 2025 | 2.519B |
| June 30, 2025 | 2.478B |
| March 31, 2025 | 2.921B |
| December 31, 2024 | 1.486B |
| September 30, 2024 | 1.433B |
| June 30, 2024 | 1.928B |
| March 31, 2024 | 2.18B |
| December 31, 2023 | 959.00M |
| September 30, 2023 | 1.378B |
| June 30, 2023 | 1.82B |
| March 31, 2023 | 1.804B |
| December 31, 2022 | 902.00M |
| September 30, 2022 | 1.642B |
| June 30, 2022 | 360.00M |
| March 31, 2022 | 388.00M |
| December 31, 2021 | -346.00M |
| September 30, 2021 | -1.651B |
| June 30, 2021 | 550.00M |
| March 31, 2021 | 1.562B |
| December 31, 2020 | 1.005B |
| September 30, 2020 | 651.00M |
| June 30, 2020 | 738.00M |
| March 31, 2020 | 750.00M |
| Date | Value |
|---|---|
| December 31, 2019 | 277.00M |
| September 30, 2019 | 280.00M |
| June 30, 2019 | 107.00M |
| March 31, 2019 | 563.00M |
| December 31, 2018 | 1.009B |
| September 30, 2018 | 406.00M |
| June 30, 2018 | 319.00M |
| March 31, 2018 | 318.12M |
| December 31, 2017 | 1.261B |
| September 30, 2017 | 649.00M |
| June 30, 2017 | 446.00M |
| March 31, 2017 | 512.00M |
| December 31, 2016 | 1.817B |
| September 30, 2016 | 994.62M |
| June 30, 2016 | -30.67M |
| March 31, 2016 | 618.90M |
| December 31, 2015 | 808.00M |
| September 30, 2015 | 770.00M |
| June 30, 2015 | 696.00M |
| March 31, 2015 | 552.00M |
| December 31, 2014 | -319.38M |
| September 30, 2014 | 251.12M |
| June 30, 2014 | 801.13M |
| March 31, 2014 | 508.18M |
| December 31, 2013 | -535.89M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| GSK Plc | 742.26M |
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
| Merck & Co., Inc. | -1.337B |
| Novo Nordisk A/S | 3.265B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 15.26B |
| Total Expenses (Quarterly) | 12.19B |
| EPS Diluted (Quarterly) | 0.9849 |
| Enterprise Value | 541.11B |
| Gross Profit Margin (Quarterly) | 76.09% |
| Profit Margin (Quarterly) | 20.15% |
| Earnings Yield | 2.00% |
| Operating Earnings Yield | 2.70% |
| Normalized Earnings Yield | 2.020 |